The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 20, 2018

Filed:

Apr. 22, 2011
Applicants:

Robert E. Sievers, Boulder, CO (US);

Stephen P. Cape, Boulder, CO (US);

David Mcadams, Seattle, WA (US);

J'aime Manion, Denver, CO (US);

Pankaj Pathak, Longmont, CO (US);

Inventors:

Robert E. Sievers, Boulder, CO (US);

Stephen P. Cape, Boulder, CO (US);

David McAdams, Seattle, WA (US);

J'aime Manion, Denver, CO (US);

Pankaj Pathak, Longmont, CO (US);

Assignee:

AKTIV-DRY LLC, Boulder, CO (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 31/047 (2006.01); A61K 9/00 (2006.01); A61K 9/16 (2006.01); A61K 9/51 (2006.01); A61K 39/12 (2006.01); A61K 39/165 (2006.01); A61K 45/06 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/047 (2013.01); A61K 9/0056 (2013.01); A61K 9/0075 (2013.01); A61K 9/1647 (2013.01); A61K 9/1688 (2013.01); A61K 9/1694 (2013.01); A61K 9/5153 (2013.01); A61K 9/5192 (2013.01); A61K 39/12 (2013.01); A61K 39/165 (2013.01); A61K 45/06 (2013.01); A61K 2039/54 (2013.01); A61K 2039/542 (2013.01); A61K 2039/543 (2013.01); A61K 2039/544 (2013.01); A61K 2039/60 (2013.01); C12N 2760/18434 (2013.01);
Abstract

Methods and products for treating and/or delaying onset of dysplastic lesions, and wafers for oral administration employ dry powder compositions including myo-inositol. Methods for administering a vaccine for a virus or bacteria to an individual comprising administering a first portion of the vaccine to the individual via one route and administering a second portion via a second, different route. In a specific embodiment, the first route is sublingually. Vaccines are provided in the form of dry powder compositions comprising a combination of nanoparticles and microparticles, or in the form of a wafer which dissolves in water at room temperature in less than about one minute. Storage stable unit dosages of a vaccine are provided by individually packaging individual unit dosages of a dry powder composition comprising the vaccine and a carrier in blister compartments formed of gas and moisture resistant material.


Find Patent Forward Citations

Loading…